DOJ and HHS launch healthcare false claims act self-disclosure pilot program
The U.S. Department of Justice (DOJ) and the Department of Health and Human Services (HHS) have introduced a six-month pilot programme to facilitate the voluntary disclosure and resolution of potential civil violations of the False Claims Act (FCA) in the healthcare sector. Announced on 22 October 2026, the initiative aims to encourage companies to identify and remediate potential misconduct while providing a more predictable framework for resolving civil liability.
The Healthcare False Claims Act Self-Disclosure Pilot Program applies to healthcare providers, suppliers, manufacturers, payors and related entities involved in federally funded healthcare programmes. Participation is subject to specific eligibility requirements, including that the potential FCA violation must not already be known to the federal government. Companies must provide detailed information about the relevant conduct, supporting documentation and remedial measures.
The authorities informed that eligible participants may benefit from a coordinated civil resolution covering the disclosed conduct and certain HHS administrative authorities. Furthermore, they communicated that the programme is limited to potential civil violations and does not replace separate disclosure arrangements for criminal healthcare fraud. It reflects the authorities’ emphasis on voluntary self-disclosure, cooperation and remediation as elements of healthcare compliance enforcement.